ReAble, DJO merger gets FTC (Federal Trade Commission) go-ahead:
This article was originally published in Clinica
ReAble Therapeutics' merger with musculoskeletal and vascular health specialist DJO Incorporated has received the green light from the US Federal Trade Commission, after it granted early termination of the required antitrust waiting period. The deal, which will see private equity company The Blackstone Group acquire Vista, California-based DJO and merge it with ReAble (see Clinica No 1265, p 11), is expected to close in the fourth quarter of 2007, and is worth approximately $1.6bn.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.